5.500
+0,00%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -33.6% | +31.2% | 2 / 3 | -24.1% | +0.51 pp | -0.05 pp | +4.7% | 3.33 | 10.81 | 1.475 | −24,1% | 4,8 | −33,6% | 10.81 | 15.94 | −32,2% |
| Pts | 0 | 4 | 8 | 0 | 8 | 4 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 5.500 (close price on 2026-10-19)EPS (TTM): 508,7
Financial charts
1.Revenue & growth
VND bn1.475Q2/26
1.Revenue & growth
VND bn1.475Q2/26
2.Profit & growth
VND bn4,80Q2/26
3.Profit mix (Penman)
VND bn19,0Q2/26
4.Margins & cost structure
%12.2%Q2/26
5.Returns & cash cycle
% · days2.6%Q2/26
6.Earnings quality & cash
VND bn-209Q2/26
7.Asset structure
VND bn1.284Q2/26
8.Funding & debt health
VND bn · times1.284Q2/26
9.Revenue backlog
VND bn4,43Q2/26
10.Valuation
times · %10,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %189Q2/26
Adjusted EPS growth, latest quarter
-33.6%
Average adjusted EPS growth, 3 quarters
-4.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26